Interleukin 6: A Friend or Foe in Diabetic Nephropathy
Open Access
- 22 February 2025
- journal article
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (4) , 1180-1190
Abstract
Introduction: This study aimed to investigate the relationship between serum cytokine levels, particularly Interleukin 6 (IL-6), and diabetic nephropathy (DN) in patients with type 1 (T1D) and type 2 diabetes (T2D).Material and methods: A cross-sectional study was conducted among 200 patients diagnosed with either T1D or T2D from January 2022 to December 2023 at the endocrinology and diabetes department of Madinah Hospital, Saudi Arabia.Results: A total of 200 individuals with type T1D (n=100) or T2D (n=100) were enrolled in this research. Male patients (54%) and those aged 30–50 (67.5%) dominated the cohort. About 50% had diabetes for less than 10 years, and 49.5% were overweight. 63.5% had reduced glomerular filtration rate, whereas 46% (n=92) had albuminuria. T1D patients were mostly normal weight, while T2D patients were overweight or obese. Both diabetes types had identical kidney damage stages. T1D patients are more likely to have moderately elevated albuminuria (53% vs. 37%, p <0.05) than T2D individuals. T1D patients had considerably lower serum cytokine levels than T2D patients. IL-6 levels were moderately correlated with fasting blood glucose (r = -0.318, p<0.01) and HbA1c (r= -0.319, p<0.01) in T1D patients. IL-6 had a modest correlation with renal dysfunction markers, including GFR and urine albumin-creatinine ratio (r= -0.250, p<0.05 and r= 0.338, p<0.001, respectively).Conclusions: Lower serum IL-6 levels in T1D patients are linked to delayed onset of kidney damage. The pro-inflammatory role of IL-6 may contribute to the development of diabetic nephropathy in T1D patients, as indicated by its association with albuminuria and renal function markers.Keywords
This publication has 18 references indexed in Scilit:
- Diabetic nephropathy and inflammationWorld Journal of Diabetes, 2014
- Inflammation in Diabetic NephropathyMediators of Inflammation, 2012
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathyNature Reviews Nephrology, 2011
- Inflammatory cytokines in vascular dysfunction and vascular diseaseBiochemical Pharmacology, 2009
- The Role of Inflammatory Cytokines in Diabetic NephropathyJournal of the American Society of Nephrology, 2008
- Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseasesNephrology Dialysis Transplantation, 2005
- Diabetic Nephropathy: Diagnosis, Prevention, and TreatmentDiabetes Care, 2005
- Appropriate body-mass index for Asian populations and its implications for policy and intervention strategiesThe Lancet, 2004
- Regression of Microalbuminuria in Type 1 DiabetesNew England Journal of Medicine, 2003
- ForewordAmerican Journal of Kidney Diseases, 2002